Advancing cell and Gene Therapy Drug Development

Emerging technologies have driven cell and gene therapies to the forefront of healthcare, addressing a growing number of disease conditions including rare diseases with unmet medical needs. CGT trials are long, incredibly complex, and riddled with unknowns, that is why advancing development in these areas requires special expertise and the ability to tailor services across all stages of drug development. PPD has deep experience partnering with clients to advance development of their cell and gene therapy trials across numerous indications and all development phases.